Heparan-sulfate proteoglycans found to influence Alzheimer’s cell pathology

FHS
July 5, 2024
9:23 am

The impact of heparan-sulfate-modified proteoglycans (HSPGs) on Alzheimer’s disease-associated pathways.

Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker

SAVANNAH, Ga. — Investigational nipocalimab plus standard of care achieved sustained reductions in immunoglobulin G (IgG) and appeared to be safe for adolescent patients with

October 20, 2024

Astellas eyes rare ophthalmology, licensing 4DMT’s viral vector for gene therapy for up to $962M

Astellas will pay 4D Molecular Therapeutics $20 million upfront to use its viral vector for a rare monogenic eye disease in a deal worth up

July 11, 2023

Genetic melting pot: Study unveils complex admixture in European ancestry populations

In a recent Nature Communications study, researchers revealed that Europeans and European Americans possess a significant subcontinental genetic admixture, challenging the notion that these populations

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.